The Sodium-Glucose Co-Transporter 2 Inhibitor Empagliflozin Improves Diabetes-Induced Vascular Dysfunction in the Streptozotocin Diabetes Rat Model by Interfering with Oxidative Stress and Glucotoxicity

• Matthias Oelze ,

  Contributed equally to this work with: Matthias Oelze, Swenja Kröller-Schön

  ¶MO and SKS should both be considered as first author.

  Affiliation 2nd Medical Clinic, Department of Cardiology, Medical Center of the Johannes Gutenberg University, Mainz, Germany

  ⨯
• Swenja Kröller-Schön ,

  Contributed equally to this work with: Matthias Oelze, Swenja Kröller-Schön

  ¶MO and SKS should both be considered as first author.

  Affiliation 2nd Medical Clinic, Department of Cardiology, Medical Center of the Johannes Gutenberg University, Mainz, Germany

  ⨯
• Philipp Welschof,

  Affiliation 2nd Medical Clinic, Department of Cardiology, Medical Center of the Johannes Gutenberg University, Mainz, Germany

  ⨯
• Thomas Jansen,

  Affiliation 2nd Medical Clinic, Department of Cardiology, Medical Center of the Johannes Gutenberg University, Mainz, Germany

  ⨯
• Michael Hausding,

  Affiliation 2nd Medical Clinic, Department of Cardiology, Medical Center of the Johannes Gutenberg University, Mainz, Germany

  ⨯
• Yuliya Mikhed,

  Affiliation 2nd Medical Clinic, Department of Cardiology, Medical Center of the Johannes Gutenberg University, Mainz, Germany

  ⨯
• Paul Stamm,

  Affiliation 2nd Medical Clinic, Department of Cardiology, Medical Center of the Johannes Gutenberg University, Mainz, Germany

  ⨯
• Michael Mader,

  Affiliation 2nd Medical Clinic, Department of Cardiology, Medical Center of the Johannes Gutenberg University, Mainz, Germany

  ⨯
• Elena Zinßius,

  Affiliation 2nd Medical Clinic, Department of Cardiology, Medical Center of the Johannes Gutenberg University, Mainz, Germany

  ⨯
• Saule Agdauletova,

  Affiliation 2nd Medical Clinic, Department of Cardiology, Medical Center of the Johannes Gutenberg University, Mainz, Germany

  ⨯
• Anna Gottschlich,

  Affiliation 2nd Medical Clinic, Department of Cardiology, Medical Center of the Johannes Gutenberg University, Mainz, Germany

  ⨯
• Sebastian Steven,

  Affiliation 2nd Medical Clinic, Department of Cardiology, Medical Center of the Johannes Gutenberg University, Mainz, Germany

  ⨯
• Eberhard Schulz,

  Affiliation 2nd Medical Clinic, Department of Cardiology, Medical Center of the Johannes Gutenberg University, Mainz, Germany

  ⨯
• Serge P. Bottari,

  Affiliation Laboratory of Fundamental and Applied, Bioenergetics, INSERM U1055, Grenoble-Alpes Université et Pôle de Biologie, CHU, Grenoble, France

  ⨯
• Eric Mayoux,

  Affiliation Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany

  ⨯
• Thomas Münzel,

  Affiliation 2nd Medical Clinic, Department of Cardiology, Medical Center of the Johannes Gutenberg University, Mainz, Germany

  ⨯
•  [ ... ],
• Andreas Daiber

  * E-mail: andreas.daiber@bioredox.com

  Affiliation 2nd Medical Clinic, Department of Cardiology, Medical Center of the Johannes Gutenberg University, Mainz, Germany

  ⨯
• [ view all ]
• [ view less ]